OppenheimerFunds’s Innophos Holdings, Inc. IPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$422K Sell
13,998
-2,636
-16% -$79.1K ﹤0.01% 1429
2018
Q4
$408K Buy
16,634
+5,090
+44% +$155K ﹤0.01% 1452
2018
Q3
$513K Buy
11,544
+1,894
+20% +$86.6K ﹤0.01% 1434
2018
Q2
$459K Sell
9,650
-1,003
-9% -$45.6K ﹤0.01% 1458
2018
Q1
$428K Sell
10,653
-284
-3% -$12.4K ﹤0.01% 1465
2017
Q4
$511K Buy
10,937
+365
+3% +$17K ﹤0.01% 1510
2017
Q3
$520K Sell
10,572
-5,761
-35% -$260K ﹤0.01% 1501
2017
Q2
$716K Buy
16,333
+6,020
+58% +$270K ﹤0.01% 1326
2017
Q1
$557K Buy
10,313
+2,330
+29% +$120K ﹤0.01% 1461
2016
Q4
$417K Sell
7,983
-1,268
-14% -$61.6K ﹤0.01% 1459
2016
Q3
$361K Sell
9,251
-21
-0.2% -$863 ﹤0.01% 1421
2016
Q2
$391K Sell
9,272
-2,923
-24% -$110K ﹤0.01% 1350
2016
Q1
$377K Sell
12,195
-1,622
-12% -$44.7K ﹤0.01% 1347
2015
Q4
$400K Buy
+13,817
New +$486K ﹤0.01% 1385

Other funds holding IPHS

OppenheimerFunds's IPHS Position: Q1 2019 in Review

OppenheimerFunds reduced its Innophos Holdings, Inc. (IPHS) stake by 16% in Q1 2019, selling an estimated $79.1K and leaving 13,998 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

OppenheimerFunds first reported a position in IPHS in Q4 2015 and has held it in 14 quarters since. The position peaked at $716K in Q2 2017. 151 funds tracked by Wall St. Rank hold IPHS as of Q1 2019.

  • OppenheimerFunds held 13,998 shares of Innophos Holdings, Inc. worth $422K as of Q1 2019.
  • OppenheimerFunds sold 2,636 Innophos Holdings, Inc. shares in Q1 2019, an estimated $79.1K.
  • Innophos Holdings, Inc. made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1429 holding.
  • OppenheimerFunds first reported a position in Innophos Holdings, Inc. in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Innophos Holdings, Inc. position peaked at $716K in Q2 2017.
  • 151 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.